AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-83 |
Results: 76-83/83
NO EFFECT OF INSULIN-TREATMENT OR GLYCEMIC IMPROVEMENT ON PLASMA CARNITINE LEVELS IN TYPE-2 DIABETIC-PATIENTS
Authors: PREGANT P KAISER E SCHERNTHANER G
Citation: P. Pregant et al., NO EFFECT OF INSULIN-TREATMENT OR GLYCEMIC IMPROVEMENT ON PLASMA CARNITINE LEVELS IN TYPE-2 DIABETIC-PATIENTS, The Clinical investigator, 71(8), 1993, pp. 610-612
THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY
Authors: ZIEGLER D GRIES FA SPULER M LESSMANN F BERGER W BERGIS K DAWEKE H DJONLAGIC H FINN JR GARZOLI G GRIES FA GRIMM JJ GRUNEKLEE D GUTSCHE P HENRICHS HR HUBNER P IRSIGLER K KOBBERLING J KRUCK F LUFT D MEHNERT H PETZOLDT R SACHSE G SAILER D SCHERNTHANER G WILLMS B
Citation: D. Ziegler et al., THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY, Diabetic medicine, 10(5), 1993, pp. 82-86
HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS
Authors: KNOBL P SCHNACK C PROIDL S PRAGER R VUKOVICH T SCHERNTHANER G
Citation: P. Knobl et al., HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS, Thrombosis and haemostasis, 69(6), 1993, pp. 806-806
PREVALENCE AND CLINICAL CORRELATES OF CARDIOVASCULAR AUTONOMIC AND PERIPHERAL DIABETIC NEUROPATHY IN PATIENTS ATTENDING DIABETES CENTERS
Authors: ZIEGLER D GRIES FA MUHLEN H RATHMANN W SPULER M LESSMANN F BERGER W BERGIS K DAWEKE H DJONLAGIC H FINN JR GARZOLI G GRIES FA GRIMM JJ GRUNEKLEE D GUTSCHE P HENRICHS HR HUBNER P IRSIGLER K KOBBERLING J KRUCK F LUFT D MEHNERT H PETZOLDT R SACHSE G SAILER D SCHERNTHANER G WILLMS B
Citation: D. Ziegler et al., PREVALENCE AND CLINICAL CORRELATES OF CARDIOVASCULAR AUTONOMIC AND PERIPHERAL DIABETIC NEUROPATHY IN PATIENTS ATTENDING DIABETES CENTERS, Diabete et metabolisme, 19(1BIS), 1993, pp. 143-151
IMMUNOGENICITY AND ALLERGENIC POTENTIAL OF ANIMAL AND HUMAN INSULINS
Authors: SCHERNTHANER G
Citation: G. Schernthaner, IMMUNOGENICITY AND ALLERGENIC POTENTIAL OF ANIMAL AND HUMAN INSULINS, Diabetes care, 16, 1993, pp. 155-165
PROSTACYCLINS IN DIABETES - AN ELECTROPHYSIOLOGICAL STUDY
Authors: LESSEL MR THALER A SCHEIBER V HEILIG P GOTTLOB I SCHERNTHANER G
Citation: Mr. Lessel et al., PROSTACYCLINS IN DIABETES - AN ELECTROPHYSIOLOGICAL STUDY, Ophthalmic research, 25(6), 1993, pp. 355-362
THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
Authors: KNOBL P SCHERNTHANER G SCHNACK C PIETSCHMANN P GRIESMACHER A PRAGER R MULLER M
Citation: P. Knobl et al., THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, Diabetologia, 36(10), 1993, pp. 1045-1050
HYPOMAGNESEMIA IN TYPE-2 DIABETES-MELLITUS - EFFECT OF AN ORAL MAGNESIUM SUPPLEMENTATION
Authors: EIBL N FESTA A SCHNACK C NOVAK H HOPMEIER P SCHERNTHANER G
Citation: N. Eibl et al., HYPOMAGNESEMIA IN TYPE-2 DIABETES-MELLITUS - EFFECT OF AN ORAL MAGNESIUM SUPPLEMENTATION, Diabetologia, 36, 1993, pp. 10000179-10000179
Risultati: 1-25 | 26-50 | 51-75 | 76-83 |